Induction Chemotherapy Followed by Chemoradiotherapy Compared With Chemoradiotherapy Alone for Regionally Advanced Unresectable Stage III Non–Small-Cell Lung Cancer: Cancer and Leukemia Group B | Zendy

Everett E. Vokes | Zendy; James E. Herndon | Zendy; Michael J. Kelley | Zendy; M. Giulia Cicchetti | Zendy; Nithya Ramnath | Zendy; H. Barry Neill | Zendy; James N. Atkins | Zendy; Dorothy Watson | Zendy; Wallace Akerley | Zendy; Mark R. Green | Zendy

Open Access

Induction Chemotherapy Followed by Chemoradiotherapy Compared With Chemoradiotherapy Alone for Regionally Advanced Unresectable Stage III Non–Small-Cell Lung Cancer: Cancer and Leukemia Group B

Author(s) -

Everett E. Vokes,

James E. Herndon,

Michael J. Kelley,

M. Giulia Cicchetti,

Nithya Ramnath,

H. Barry Neill,

James N. Atkins,

Dorothy Watson,

Wallace Akerley,

Mark R. Green

Publication year - 2007

Publication title -

journal of clinical oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 10.482

H-Index - 548

eISSN - 1527-7755

pISSN - 0732-183X

DOI - 10.1200/jco.2006.07.3569

Subject(s) - medicine , chemoradiotherapy , carboplatin , induction chemotherapy , chemotherapy , lung cancer , radiation therapy , concomitant , neutropenia , gastroenterology , surgery , stage (stratigraphy) , oncology , cisplatin , paleontology , biology

Standard therapy for unresectable stage III non-small-cell lung cancer includes concomitant chemoradiotherapy. In Cancer and Leukemia Group B 39801, we evaluated whether induction chemotherapy before concurrent chemoradiotherapy would result in improved survival.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research